Stellaromics today launched Pyxa™, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100 micrometers thick. The launch marks a ...

Advances in 3D spatial multiomics are changing how researchers study tissue architecture. We spoke with Stellaromics' CEO, Dr. Todd Dickinson, to learn how this approach preserves structure and ...

Researchers have installed a high-resolution 3D spatial multi-omics system to study RNA regulation in intact brain tissue, ...

Dr. Hailing Shi to apply 3D spatial multi-omics to decode RNA regulation in the human brain and neurodegenerative diseases BOSTON, Jan. 28, 2026 /PRNewswire/ -- Stellaromics, a pioneer in ...

BOSTON, Oct. 14, 2025 /PRNewswire/ -- Stellaromics, a pioneer in 3D spatial biology, today announces the installation of the first Pyxa™ instrument at the University of Glasgow in the laboratory of Dr ...

Renowned vision researcher Dr. Rui Chen to apply 3D spatial multi-omics for mapping sensory systems and advancing Human Cell Atlas discoveries BOSTON, Dec. 3, 2025 /PRNewswire/ -- Stellaromics, a ...

In the rapidly developing field of spatial biology, researchers are working to expand our understanding of biological processes within their spatial context. Scientists are taking a holistic approach ...

Neoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial. This is an ASCO ...

Conventional transcriptomic techniques have revealed much about gene expression at the population and single-cell level—but they overlook one crucial factor: spatial context. In musculoskeletal ...